ACED

Aionics, Inc. and Carnegie Mellon University Announce Licensing Agreement for Breakthrough Battery Electrolyte Design Software

Retrieved on: 
Thursday, September 7, 2023
Transfer, Electrolyte, Inc., Technology transfer, PALO, Research, ACED, Associate, State, Carnegie Mellon University, Artificial intelligence, CMU, Viswanathan, Cryptocurrency, Discovery

Aionics, Inc. is a Palo Alto-based startup that uses artificial intelligence and quantum mechanical simulation to design next generation materials for batteries and other energy technologies.

Key Points: 
  • Aionics, Inc. is a Palo Alto-based startup that uses artificial intelligence and quantum mechanical simulation to design next generation materials for batteries and other energy technologies.
  • The company regularly screens millions to billions of candidate electrolyte formulations in its partnerships with leading battery manufacturers, automotive companies, and others.
  • Viswanathan added: “Witnessing the transition of our computational design tools for electrolyte design and optimization from research to full-fledged commercialization through Aionics is an electrifying moment.
  • This stack represents the most advanced electrolyte design and optimization tool with the effort of dozens of researchers behind it."

Govee Elevates the Gaming Experience: Announces the Availability of the First AI Gaming Sync Box Kit and a Brand New Neon Rope Light for Desks

Retrieved on: 
Monday, March 27, 2023
Life, First Blood, Deep learning, Overwatch 2, HDMI, ACED, Amazon, Apex Legends, VALORANT, AI, League of Legends, Video game, Phosphorus, Television, EU, League, Gove Scrivenor

In addition, the brand new RGBIC Neon Rope Light for Desks (available April 10, 2023) can work in tandem with the Govee AI Gaming Sync Box and other lights in the Govee ecosystem to make gaming setups even more captivating.

Key Points: 
  • In addition, the brand new RGBIC Neon Rope Light for Desks (available April 10, 2023) can work in tandem with the Govee AI Gaming Sync Box and other lights in the Govee ecosystem to make gaming setups even more captivating.
  • Now, it's entering the game lighting sphere with the first-ever AI-powered gaming lights – the AI Gaming Sync Box Kit.
  • Whether you ACED in VOLARANT or get First Blood in League of Legends, the AI Gaming Sync Box Kit will display complementary lighting effects for incredible visual impact.
  • The next addition to the gaming light lineup is the Govee RGBIC Neon Rope Light for Desks.

Khiron presents its first research study with 1,400 patients

Retrieved on: 
Thursday, October 7, 2021
Company, Patient, Observational study, Insomnia, Trial of the century, Publication, IASP, International Association, Comment, Prescription, Conference, Nausea, Intention, International Association for the Study of Pain, Nigerian National Health Research Ethics Committee, Multimedia, Chronic pain, Board of directors, Female, SEDAR, Spasticity, Vomiting, THC, Depression, ACED, Nature, Social, Cannabinoid, Policy, Social Security Amendments of 1965, Anxiety, Risk, Research, Legislation, Social Security, Pharmaceutical industry, Fine chemical

The study, entitled "Prescription patterns and clinical outcomes in a cohort of patients receiving progressive therapy with cannabinoids for medical use in Colombia", is a longitudinal, retrospective cohort study including 1,453 patients receiving treatment with medical cannabis at Khiron-owned clinics in Colombia, Zerenia and ILANS.

Key Points: 
  • The study, entitled "Prescription patterns and clinical outcomes in a cohort of patients receiving progressive therapy with cannabinoids for medical use in Colombia", is a longitudinal, retrospective cohort study including 1,453 patients receiving treatment with medical cannabis at Khiron-owned clinics in Colombia, Zerenia and ILANS.
  • The research protocol was reviewed and approved by the Scientific Institutional Committee and the Research Ethical Committee of the Universidad del Bosque, in Colombia, one of the leading institutions on medical research in the region.
  • Study results show a patient-reported positive clinic response in more than 80% of participants with only minor side-effects associated to the treatment.
  • Khiron undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of Khiron, its securities, or financial or operating results (as applicable).